Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

The ODAC Losing Streak Ends

Mar 15 2023

• By Michael McCaughan

checkered flag — • Source: Shutterstock

Related Content

GSK’s Blenrep: 15 Days From Confirmatory Trial Failure To Withdrawal Announcement

Nov 28 2022

US FDA’s ODAC: The Advisory Committee That Can Only Say ‘No’

Nov 01 2022

GlaxoSmithKline Survives Technical Woes To Win US FDA Panel Nod For Belantamab

Jul 15 2020

Genentech Polivy’s Benefit-Risk Profile In First-Line Lymphoma Under Scrutiny

Mar 07 2023

Genentech’s Polivy Gets US FDA Panel Nod For First-Line Use In Large B-Cell Lymphoma

Mar 10 2023

Related Companies

Genentech, Inc.

GSK plc

Additional Topics

United States Advisory Committees Drug Review Drug Approval Standards Regulation Cancer BioPharmaceutical

More from US FDA Performance Tracker

More from Regulatory Trackers

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window